Fuld

MARCH 4, 2024

Fuld’s partnership with Finalis fills gaps in internal support requirements for Finalis’ clients, giving them access to Fuld’s full range of specialized services tailored for IBs , particularly those that do not have internal research teams.

Communication 64

Communication 64

pharmaphorum

JANUARY 4, 2022

Push Doctor – a digital platform that virtually connects patients with GPs – has been acquired by private healthcare service provider Square Health for an undisclosed fee. A push into partnering with primary care networks (PCNs) and clinical commissioning groups (CCGs) within the NHS means it now provides services to around 5.7

Insurance 94

Insurance 94

Fuld

MAY 15, 2023

The themes we highlight in this month’s newsletter all point toward the importance of strategic agility and adaptability in today’s ever-changing business landscape. Please reach out if you would like to discuss how these topics are relevant to your business. Do you want to be one step ahead in the game?

52

52

pharmaphorum

OCTOBER 25, 2021

Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector. Adding Lemonaid marks another expansion of its focus into primary care delivery, according to Anne Wojcicki, the company’s chief executive and co-founder.

Vaccines 111

Vaccines 111

European Pharmaceutical Review

NOVEMBER 30, 2023

o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans. Future growth of the ATMP sector Ward highlighted a key change in the recruitment space.

Medical Schools 71

Medical Schools 71

Pharmaceutical Technology

DECEMBER 19, 2022

Business Expansion. Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole. Investments.

52

52

pharmaphorum

JANUARY 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. He holds a Master of Business Administration from The University of Texas at Austin.

Communication 98

Communication 98

Pharmaceutical Technology

AUGUST 4, 2022

Business optimism declined in July 2022 compared to June 2022, amid concerns over inflation as the cost-of-living pressures on households continued to grow in countries such as the UK, revealed the analysis of an ongoing poll by Verdict. Business confidence falls three points to 25% in the UK. believed it would decrease.

Hospitals 52

Hospitals 52

Pharma Mirror

MAY 21, 2021

Contract services experts at this week’s CPhI Discover – (17-28th May, 2021) – the largest ever online pharma event featuring content in the opening week and networking in week two – point to pandemic contracts delivering a significant boon to the CDMO sector, but forewarn of exacerbated shortages for viral vector manufacturing.

52

52

The FDA Law Blog

FEBRUARY 5, 2024

With regulations varying significantly from one state to another, companies in these sectors often find themselves immersed in a labyrinth of compliance requirements. It is critical for companies to stay abreast of current laws and regulations to avoid costly penalties and business disruptions.

Controlled Substances 45

Controlled Substances Documentation Communication 45

Fuld

AUGUST 26, 2022

BOSTON – Aug 25, 2022 – Phronesis Partners and Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Elaine Pratt to the role of Group Chief Marketing Officer. ” About Fuld & Company. www.fuld.com.

Communication 52

Communication 52

Fuld

DECEMBER 5, 2021

Business & Industry Research. Our business and industry research offerings help clients make more informed and effective decisions. From conducting detailed market due diligence procedures to meeting urgent data requirements, our research services support all business processes, client sectors, and geographical areas.

52

52

pharmaphorum

SEPTEMBER 22, 2021

The third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on the lessons he learned from his father and grandfather – and from his work as a former management consultant – about what it means to run a successful family business and its benefits.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Immunization 111

pharmaphorum

APRIL 1, 2022

Uday Bose is a highly experienced and successful leader in the pharmaceutical industry within the human pharma sector, with over 25 years’ experience spanning general management, health economics, sales and marketing roles with National (UK/Ireland), Regional (EMEA) and Global accountability.

98

98

Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Business confidence remains equivalent to long-term average in the UK. The East of England reported the highest increase in business confidence from 14% to 31%.

52

52

Pharmaceutical Technology

NOVEMBER 1, 2022

FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. The Product Launches category recognises companies that have launched notable new products or services into the market. What are Product Launches?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

NOVEMBER 25, 2020

Trio Health’s Neil McGregor-Paterson asks whether the healthcare industry has paid enough attention to the patient voice during COVID-19 and looks at the many ways pharma can improve the patient experience across the sector going forward. All with a speed and agility that could never be replicated by providers.

Hospitals 115

Hospitals Vaccines 115

pharmaphorum

AUGUST 9, 2021

Telstra Health managing director Mary Foley said that the acquisition adds to the company’s current range of digital health tools used by hospitals, pharmacies and the aged care sector.

Hospitals 105

Hospitals 105

pharmaphorum

AUGUST 4, 2022

Businesses need to ensure they prioritise the recruitment and development of staff to help ensure longevity and survival. In a job market characterised by talent shortages, the onus is on businesses to provide the workforce with attractive job opportunities. Embrace mobile learning.

Customer Service 98

Customer Service Vaccines 98

pharmaphorum

MAY 13, 2022

“Increasingly, we’re moving from a traditional physician office setting to virtual engagement and more payers are reimbursing for digital services.”. Fonseca concluded: “Rather than create a digital strategy for your business, we should be creating a business strategy for a digital world.”. About the author.

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 131

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Pharmaceutical Technology has listed the top speciality pharmacies in pharma based on its intel, insights, and decades of experience in the sector.

Documentation 45

Documentation Clinic Management Communication Patient Care 45

Pharmaceutical Technology

SEPTEMBER 6, 2022

Business optimism improved in August 2022 compared to July 2022, according to an ongoing poll by Verdict, despite businesses expressing concern over inflation, particularly in raw materials and energy costs. Business confidence improves in three of the UK’s regions. Indian firms witness stronger growth and softer cost pressures.

52

52

pharmaphorum

FEBRUARY 10, 2022

With staff shortages and digital skill gaps being experienced across the spectrum of healthcare, from CROs and pharma to providers, the people-led sector is facing a personnel challenge that could threaten the potential of digital transformation. COVID brain drain. In the UK, for example, the NHS went into the pandemic with 100,000 vacancies.

Compounding 105

Compounding 105

PharmaShots

JUNE 14, 2023

The diagnostic and testing companies have been serving as a pivotal foundation stone of the healthcare sector With a global market value of $165.58B in 2021, the diagnostic and testing market size is anticipated to touch the threshold of $348.75 The company divides its business into Life Science and Clinical Diagnostic Segments.

FDA 56

FDA Hospitals Documentation Patient Care 56

Pharmaceutical Technology

JULY 19, 2022

ESG needs to be at the core of any healthcare company or institution that wants to continue to provide quality care and services. This is particularly true for pharma, which has struggled with a poor reputation for years due to high prices of drugs and unethical business practices.

Hospitals 64

Hospitals Vaccines 64

Pharmaceutical Technology

SEPTEMBER 7, 2022

Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing decision.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

PQA

FEBRUARY 9, 2024

The benefits of sponsorship include recognition as a national leader in quality, occasions to build strategic partnerships, the generation of business leads through brand exposure, and insights on market trends and best practices. Review these opportunities in the Sponsorship Prospectus, learn more below and connect with me. Register here.

59

59

Fuld

JANUARY 24, 2023

BOSTON – Jan 24, 2023 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Charles Collier to the role of Senior Vice President, Consulting Research & Analytics. The Fuld team is thrilled to have Charles leading business development in the private equity space.”

52

52

European Pharmaceutical Review

MAY 23, 2023

This makes it the second most important sector after ICT, the research found. One reason many of these biotechs are choosing Switzerland is its business-friendly environment. Sixty three out of a total of 265 companies settling in Switzerland were biotechs. Why are European biotech’s choosing Switzerland?

106

106

PharmaShots

MAY 10, 2023

Stock Exchange: ETR With healthcare solutions and services extending all around the globe, Siemens Healthineers is a Germany-based organization that provides healthcare services through scalable solutions. The company has divided its business into four segments i.e., Imaging, Diagnostics, Varian, and Advanced Therapies.

Nursing Homes 40

Nursing Homes Hospitals FDA Communication 40

pharmaphorum

JANUARY 10, 2023

But, although the healthcare data gold rush is outstripping sectors such as financial services, consumer goods, manufacturing, and media and entertainment, there is a danger that opportunities are slipping through the grasp of many companies. billion by 2026, according to research by the Business Research Company.

Compounding 98

Compounding Insurance Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 29, 2023

Therefore, to assist healthcare’s vital acceleration, Societe Generale has designated it one of four priority sectors. The rapid pace of growth and change means healthcare companies need our services, such as access to finance and capital markets, or strategic mergers and acquisitions advice. But this was just the tip of the iceberg.

Nursing Homes 98

Nursing Homes Hospitals Vaccines 98

pharmaphorum

MARCH 2, 2022

Hundreds of business leaders in the life sciences sector have added their names to an open letter that says they will cease all business dealings in Russia in response to Russia’s unprovoked invasion of Ukraine. With the exception of food and medicines, they also pledge to halt trade in goods with Russian companies.

52

52

pharmaphorum

JANUARY 6, 2022

Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division. In that respect it follows a similar model to Merck’s takeover of AmpTec, another CDMO that uses a PCR platform to make mRNA drugs, for an undisclosed sum last year.

Vaccines 98

Vaccines 98

Pharmaceutical Technology

NOVEMBER 4, 2022

The staff in the US from the acquired business will be retained by Reaction to set up its presence in Hershey, which comprises in vitro and in vivo expertise. This will further extend Reaction's industry-leading drug discovery service suite for customers in the biopharmaceutical sector. at closing. in exit expenses.

52

52

European Pharmaceutical Review

FEBRUARY 3, 2023

The new facility in France will aid small-scale commercial production for the sector. The 9,500m 2 facility will harness state-of-the-art containment technologies, Baduel confirmed. The HPAPI market A 2022 market report showed that due to the small volumes required for dosage, small-scale providers are also gaining importance.

Dosage 88

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 88

pharmaphorum

MAY 12, 2022

People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity. Hughes said: “Patient services is a very scripted part of the business. Among those who selected “do not trust”, however, the figure was 53%.

Communication 98

Communication Vaccines 98